ITUS Corporation Announces Second Commercial Focus for Cchek(TM) will be Breast Cancer

SAN JOSE, Calif., July 6, 2018 -- (Healthcare Sales & Marketing Network) -- ITUS Corporation (NASDAQ: ITUS) today announced that due to the significance of positive results as well as strong commercial interest, it has selected breast cancer as the next c... Diagnostics, Oncology ITUS Corporation, Cchek , liquid biopsy, prostate cancer, breast cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news